Exabis Library
Welcome to the e-CCO Library!
P168: Matrix Gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in Crohn’s Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P168: Predicting outcome in acute severe ulcerative colitis: Comparison of the Oxford, Edinburgh, Lindgren and endoscopic Mayo scores
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P168: Validation of the red flags index for early referral of patients with symptoms and signs suggestive of Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P169 Balloon enteroscopy in small bowel Crohn’s disease (CD) with suspected bleeding
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P169: A consensus of outcome measures to monitor and enhance the quality of an inflammatory bowel disease surgical service provision: results from a pan-European, multicentre, Delphi study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P169: Bowel ultrasound is accurate in assessing disease extent and disease activity in ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P169: Copy number variation of alpha defensin 1-3 is a predictive marker of therapeutic response in ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P169: Delayed diagnosis of inflammatory bowel disease in women: Characterization and use of health resources
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P169: Infliximab trough levels after induction therapy are predictive for infliximab efficacy in paediatric patients with inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P169: Usability of a home-based test for the measurement of fecal calprotectin in IBD patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P169: Vitamin D levels are inversely associated with inflammation in pediatric InflammatoryBowel Disease patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P170 Clinical characteristics of inflammatory bowel disease associated to hydradenitis suppurativa
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P170: Azathioprine metabolite (6-TGN) levels within a defined therapeutic range are associated with lower faecal calprotectin in Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P170: Can histological activity of ulcerative colitis be predicted by assessment of the rectosigmoid colon?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P170: Correlation between health-related quality of life and smartphone-based self-assessment of activity index in patients with ulcerative colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P170: Diagnostic criteria for IBD subtype classification: a multi-centre validation cohort
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P170: Faecal osteoprotegerin correlates with disease activity and predicts disease relapse in paediatric inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P170: Integrated psychological care in outpatients with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P170: Point-of-care ultrasound accurately quantifies skeletal muscle index in patients with Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P171 Does microscopic involvement of the surgical margins after ileocececal resection in Crohn’s disease patients predicts early recurrence?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM